Document is current
Any future updates will be listed below
-
Authors
Kuang, Andrew G.
Sperling, Gabriel
Liang, Tom Z.
Lu, Yang
Tan, Dongfeng
Bollin, Kathryn
Johnson, Douglas B.
Manzano, Joanna-Grace M.
Shatila, Malek
Thomas, Anusha S.
Thompson, John A.
Zhang, Hao Chi
Wang, Yinghong
- License Information
-
More Information
Article History
Received: 3 April 2023
Accepted: 18 April 2023
First Online: 17 May 2023
Declarations
:
: D.B.J. has served on advisory boards or as a consultant for BMS, Catalyst Biopharma, Iovance, Jansen, Mallinckrodt, Merck, Mosaic ImmunoEngineering, Novartis, Oncosec, Pfizer, Targovax, and Teiko and has received research funding from BMS and Incyte. The other authors declare no conflicts of interest.
: The ethics approval for this study was granted by the institutional review board at The University of Texas MD Anderson Cancer Center (PA18-0472).
: Patient consent was waived for this study.
: Patient consent was waived for this study.
